ROR1 and neoplasm: KAN0441571C is the second generation of a ROR1 tyrosine kinase inhibitor (TKI) that induced apoptosis and death of DLBCL cells and small cell carcinoma of the lung, and that acted synergistically with venetoclax on tumor cell apoptosis [13,47].